# ENTROPY RESET PROTOCOL — Somatic Cell

**Goal:** Reset cellular entropy in a somatic cell the way nature does between meiosis I and the first blastomeres — centriole elimination followed by de novo synthesis — but **without loss of the diploid chromosome set and without crossing-over.**

**Version:** 1.0 | **Date:** 2026-08-11 | **Author:** Jaba Tqemaladze, MD (Georgia Longevity Alliance)

---

## 1. What Nature Does (the Template)

Between the first meiotic division and the synthesis of centrioles in the first blastomeres, the organism performs a complete **hardware reset** of the cell:

| Step | Event | Effect |
|:---:|------|--------|
| 1 | Meiosis I — oocyte eliminates its centrioles | Acentriolar spindle; centriolar entropy is discarded with the organelle |
| 2 | Fertilization — sperm delivers a centriole | The paternal centriole becomes a **seed**, not a template |
| 3 | First blastomeres — centrioles are synthesized **de novo** from the seed | Fresh organelle, zero accumulated damage |
| 4 | Result | Structural (centriolar) entropy = 0 at the start of every generation |

**The price nature pays:** haploidization (loss of the diploid set), crossing-over (genome shuffling), and fusion of two gametes.

**The question of ARGUS-OS3 / CEDAR:** can the same reset be achieved in a **somatic** cell — elimination → de novo assembly — while keeping the diploid genome intact and skipping crossing-over entirely?

---

## 2. The Somatic Protocol (Diploid-Preserving Reset)

### Phase 1 — Elimination (meiosis-like step)

Remove all centrioles from the somatic cell, mirroring oocyte elimination at meiosis I.

| Method | Agent | Notes |
|:---:|------|-------|
| **A. Chemical** | Centrinone (PLK4 inhibitor) | Blocks centriole duplication; >95% centriole loss within 3 days (Renzova et al. 2018) |
| **B. Physical** | 405 nm pulsed laser ablation | Complete removal; single-centriole presence suppresses the de novo pathway (Khodjakov et al. 2002) |
| **C. Genetic** | Inducible PLK4 / STIL knockout | Cleanest for stable lines; requires inducible system |

**Critical rule:** elimination must be **complete**. One surviving centriole suppresses the de novo assembly pathway (Khodjakov et al. 2002). Verify with centrin-GFP loss in 100% of treated cells before proceeding.

### Phase 2 — De novo Assembly (blastomere-like step)

Release the cell from inhibition and allow centrioles to be synthesized de novo, mirroring the first blastomeres.

- Withdraw centrinone / switch off the knockout / allow recovery.
- De novo assembly proceeds through the canonical pathway (PLK4 → STIL → SAS-6 cartwheel → tubulin cylinder).
- The cell builds **fresh centrioles with zero accumulated entropy** — the blastomere outcome.
- Optionally reinforce with mild STIL/PLK4 overexpression during the recovery window to raise de novo efficiency.

### Phase 3 — Verification (entropy reset confirmed)

| Readout | Method | Expected |
|---------|--------|----------|
| Centriole integrity | EM / centrin-GFP | Normal ultrastructure, fresh organelle |
| Ploidy | Karyotype / FISH | **Diploid preserved** — no haploidization |
| Genome stability | No crossing-over | Unchanged allelic configuration |
| Entropy marker | GT335 (polyglutamylation) | Low — fresh tubulin |
| Fate markers | Lineage / reprogramming assay | Increased plasticity (CEDAR prediction) |

---

## 3. What This Tests (link to ARGUS-OS3)

ARGUS-OS3 asks: *does changing the centriole change the cell's fate?* The Entropy Reset Protocol is the **direct application**: eliminate the aged centriole, rebuild it de novo, and ask whether the cell behaves as younger.

- **System A (ablation, Drosophila NB)** — tests NECESSITY: without the centriole, does fate change?
- **System B (transplantation)** — tests SUFFICIENCY: does a foreign centriole change fate?
- **This protocol** — tests RESTORATION: after full elimination + de novo assembly, is the cell's fate reset?

If the reset cell shows rejuvenated markers and restored plasticity while remaining diploid, the centriole is confirmed as the carrier of accumulated entropy — and the germline trick has been reproduced in a somatic cell without paying the meiotic price.

---

## 4. Controls

| Control | Purpose |
|---------|---------|
| Untreated cells, same passage | Baseline |
| Centrinone-only (no recovery) | Confirms elimination phenotype |
| Recovery without de novo boost | De novo efficiency baseline |
| p53 inhibition (Pifithrin-α) | Rules out stress/apoptosis artifact |
| Buffer-only / mock injection | Mechanical stress control |
| UV-killed centriole re-injection | Rules out "foreign body" effect |

---

## 5. Timeline & Budget (indicative)

| Phase | Duration | Budget |
|:---:|:---:|:---:|
| Phase 1 elimination | 4–6 weeks | $25K |
| Phase 2 de novo assembly | 4–6 weeks | $20K |
| Phase 3 verification | 6–8 weeks | $35K |
| **Total** | **4–5 months** | **~$80K** |

Fits inside the ARGUS-OS3 envelope ($477–557K, 36–48 months) as a new work package or standalone pilot.

---

## 6. Key References

| # | Reference | PMID | Role |
|---|-----------|------|------|
| 1 | Kalbfuss & Gönczy (2023) — programmed centriole elimination | 37963546 | Germline elimination template |
| 2 | Khodjakov et al. (2002) — de novo centrosome formation | 12356862 | De novo feasibility + suppression rule |
| 3 | Renzova et al. (2018) — centrinone, centriole loss | — | Chemical elimination |
| 4 | Thomas & Giet (2022) — live imaging, photo-ablation | — | Ablation protocol |
| 5 | Gallaud et al. (2014) — post-ablation defects | 24687279 | Survivor-bias mitigation |
| 6 | Rhee (2021) — supernumerary centrioles, p53 | 34711687 | Quantity control |

---

*Part of the ARGUS-OS3 / CEDAR program — "the germline trick, reproduced in a dish, without the meiotic price."*
